Search
for
Sort by
Research 661–690 of 1000+
- An Open Randomised Clinical Study to Evaluate the Combined Effect of Krishna Tila Kashayam and Shatapuspa Choornam in PCOS
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Diagnostic Challenges in Ovarian Hyperthecosis: Clinical Presentation with Subdiagnostic Testosterone Levels
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women
- Correlation of cutaneous manifestations with body mass index, blood glucose, and hormonal levels in patients with polycystic ovarian disease
- Confluent and Reticulated Papillomatosis Associated with Polycystic Ovarian Syndrome
- Diagnosing polycystic ovary syndrome
- The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women
- Hair loss in elderly women
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Design of a RADA16-based self-assembling peptide nanofiber scaffold for biomedical applications
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Dormancy in the stem cell niche
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients
- A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy
- Secondary amenorrhea
- The Role of Heat Shock Proteins in the Pathogenesis of Polycystic Ovarian Syndrome: A Review of the Literature
- Cytokines
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier
- Investigating RNA-Seq-based differential gene expression during hair follicle development in Angora goat skin
- SAT-210 When Acne, Hirsutism and Menstrual Irregularities Are More Than PCOS
- 200 The relationship between the expression of cytokeratin 5/6 and clinicopathologic factors in invasive breast carcinoma
- High-Grade Ovarian Serous Carcinoma Presenting as Androgenetic Alopecia
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient